Larry D. Taber is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biochemistry, particularly in the isolation of bioactive growth hormones. His innovative work has led to advancements in the understanding and application of growth hormones in various medical and scientific fields.

Latest Patents

Larry D. Taber holds a patent for the "Isolation of bioactive, monomeric growth hormone." This patent describes a method for isolating monomeric, biologically active growth hormone from microbially-produced insoluble inclusion bodies. The process involves solubilizing and denaturing the growth hormone by extracting the inclusion bodies into a guanidine salt solution, such as guanidine hydrochloride. Subsequently, the growth hormone is renatured by replacing the guanidine salt solution with a denaturant-free buffer solution, followed by the removal of precipitated impurities and growth hormone aggregates. The renatured growth hormone is then purified using ion-exchange chromatography.

Career Highlights

Larry D. Taber has worked with International Minerals & Chemical Corporation, where he has applied his expertise in biochemistry to develop innovative solutions. His work has been instrumental in advancing the understanding of growth hormones and their applications in various fields.

Collaborations

Some of Larry D. Taber's notable coworkers include Ren-der Yang and Edwin J. Hamilton, Jr. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Larry D. Taber's contributions to the field of biochemistry, particularly in the isolation of growth hormones, highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the industry and pave the way for future research and applications.